37
Views
4
CrossRef citations to date
0
Altmetric
Case Report

Intravitreal bevacizumab for macular edema due to proton beam radiotherapy: Favorable results shown after eighteen months follow-up

, , , &
Pages 249-252 | Published online: 21 May 2010

References

  • BrownGCShieldsJASanbornGAugsburgerJJSavinoPJSchatzNJRadiation retinopathyOphthalmology198289149415017162794
  • WaraWMIrvineARNegerREHowesELJrPhillipsTLRadiation retinopathyInt J Radiat Oncol Biol Phys197958183422419
  • IrvineARAlvaradoJAWaraWMMorrisBWWoodISRadiation retinopathy: An experimental model for the ischemic-proliferative retinopathiesTrans Am Ophthalmol Soc1981791031227342397
  • MissottenGSNottingICSchlingemannROVascular endothelial growth factor A in eyes with uveal melanomaArch Ophthalmol20061241428143417030710
  • BoydSRTanDBunceCVascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic windowBr J Ophthalmol20028636836911914199
  • ShieldsCLDemirciHDaiVIntravitreal triamcinolone acetonide for radiation maculopathy after plaque radiotherapy for choroidal melanomaRetina20052586887416205566
  • FingerPTRadiation retinopathy is treatable with anti-vascular endothelial growth factor bevacizumab (Avastin)Int J Radiat Oncol Biol Phys200815;70497497718313522
  • MasonJO3rdAlbertMAJrPersaudTOVailRSIntravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanomaRetina200727790390717891015